The University of Texas Medical Branch · 1 month ago
Research Associate I, Microbiology and Immunology - Galveston
United States-Texas-Galveston
Full-time
Onsite
New Grad, Entry Level
0+ years expThe University of Texas Medical Branch is a prominent healthcare institution, and they are seeking a Research Associate I in Microbiology and Immunology. This role involves performing standardized laboratory assignments and experiments under direct supervision, contributing to research efforts in the field.
Responsibilities
Under direct supervision, performs standard research assignments involving a series of related operations
Sets up and conducts standard research experiments following detailed technical instructions
Prepares biological assays and conducts basic quantitative and qualitative analysis
Maintains records of all tests performed and data collected
Assists in the compilation and tabulation of data and provides preliminary analysis
Assembles, calibrates, operates and makes minor modifications to a variety of laboratory equipment as defined by appropriate guidelines
Adheres to internal controls established for department
Performs related duties as required
Qualification
Required
Bachelor's degree in basic science or equivalent
no experience required
Biological Analysis
Quantitative Analysis
Qualitative Analysis
Tabulation of Data
Equipment Calibration
Standard Laboratory Equipment
Company
The University of Texas Medical Branch
The University of Texas Medical Branch is a component of the University of Texas System located in Galveston, Texas
10001+ employees
H1B Sponsorship
The University of Texas Medical Branch has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (73)
2024 (66)
2023 (52)
2022 (57)
2021 (49)
2020 (50)
Funding
Current Stage
Late StageTotal Funding
$35MKey Investors
National Institute of Allergy and Infectious Diseases
2024-09-13Grant
2019-04-09Grant· $35M
Leadership Team
Donna Sollenberger
EVP and CEO, Health System
Recent News
2025-10-30
Quetzal Therapeutics
2025-09-17
EIN Presswire
2025-08-25
Company data provided by crunchbase